The cannabis company is now putting its focus on premium products since the value side fell apart.
Tread carefully so you don't get hit with a dilutive offering well below the market.
It seems depression may be the condition that propels psychedelics to be accepted.
Let's review the charts of this cannabis firm to see if a sustained advance is ready to begin.
Companies are adding capacity and outlets to take advantage of voters' decision this week to legalize adult-use cannabis.
Looking at these companies should not be a 'here today, gone tomorrow' fad.
Be willing to stand aside right now unless you are comfortable with a truly unknown catalyst.
As cannabis stocks have taken shareholders on a roller coaster ride, the REITs may be the safest place to go.
The potential of legal New York adult-use cannabis sales have been estimated at $1.5 billion a year by 2023.
Cannabis investors are keenly aware of the landscape and how it could play out for the industry.